{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:53:41Z","timestamp":1793753621861,"version":"4.6.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T00:00:00Z","timestamp":1526688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Queen's University of Belfast"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00417-018-4009-6","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T08:06:07Z","timestamp":1526717167000},"page":"1411-1418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy"],"prefix":"10.1007","volume":"256","author":[{"given":"Michael","family":"Mikhail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Lois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,19]]},"reference":[{"key":"4009_CR1","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","volume":"120","author":"JS Duker","year":"2013","unstructured":"Duker JS, Kaiser PK, Binder S et al (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611\u20132619. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2013.07.042","journal-title":"Ophthalmology"},{"key":"4009_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ajo.2007.07.012","volume":"144","author":"NG Ghazi","year":"2007","unstructured":"Ghazi NG, Ciralsky JB, Shah SM et al (2007) Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface. Am J Ophthalmol 144:747\u2013754.e2. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2007.07.012","journal-title":"Am J Ophthalmol"},{"key":"4009_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/bjo.2005.072934","volume":"90","author":"SP Shah","year":"2006","unstructured":"Shah SP, Patel M, Thomas D et al (2006) Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study. Br J Ophthalmol 90:33\u201336. \n                    https:\/\/doi.org\/10.1136\/bjo.2005.072934","journal-title":"Br J Ophthalmol"},{"key":"4009_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ophtha.2009.10.040","volume":"117","author":"JA Haller","year":"2010","unstructured":"Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H et al (2010) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 117:1087\u20131093.e3. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2009.10.040","journal-title":"Ophthalmology"},{"key":"4009_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0161-6420(92)31901-3","volume":"99","author":"H Lewis","year":"1992","unstructured":"Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99:753\u2013759","journal-title":"Ophthalmology"},{"key":"4009_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajo.2006.04.023","volume":"142","author":"BY Kim","year":"2006","unstructured":"Kim BY, Smith SD, Kaiser PK (2006) Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 142:405\u2013412.e1. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2006.04.023","journal-title":"Am J Ophthalmol"},{"key":"4009_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/eye.2009.106","volume":"24","author":"A Ophir","year":"2010","unstructured":"Ophir A, Trevino A, Fatum S (2010) Extrafoveal vitreous traction associated with diabetic diffuse macular oedema. Eye 24:347\u2013353. \n                    https:\/\/doi.org\/10.1038\/eye.2009.106","journal-title":"Eye"},{"key":"4009_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/J.TJO.2012.05.001","volume":"2","author":"C-K Chang","year":"2012","unstructured":"Chang C-K, Cheng C-K, Bai C-H et al (2012) Development of vitreomacular interface abnormality in patients with diabetic macular edema. Taiwan J Ophthalmol 2:93\u201398. \n                    https:\/\/doi.org\/10.1016\/J.TJO.2012.05.001","journal-title":"Taiwan J Ophthalmol"},{"key":"4009_CR9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/bjophthalmol-2014-305966","volume":"99","author":"I Akbar Khan","year":"2015","unstructured":"Akbar Khan I, Mohamed MD, Mann SS et al (2015) Prevalence of vitreomacular interface abnormalities on spectral domain optical coherence tomography of patients undergoing macular photocoagulation for centre involving diabetic macular oedema. Br J Ophthalmol 99:1078\u20131081. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305966","journal-title":"Br J Ophthalmol"},{"key":"4009_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00417-016-3562-0","volume":"255","author":"Y Wong","year":"2017","unstructured":"Wong Y, Steel DHW, Habib MS et al (2017) Vitreoretinal interface abnormalities in patients treated with ranibizumab for diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 255:733\u2013742. \n                    https:\/\/doi.org\/10.1007\/s00417-016-3562-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4009_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/eye.2016.317","volume":"31","author":"C-K Chang","year":"2017","unstructured":"Chang C-K, Cheng C-K, Peng C-H (2017) The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF. Eye (Lond) 31:762\u2013770. \n                    https:\/\/doi.org\/10.1038\/eye.2016.317","journal-title":"Eye (Lond)"},{"key":"4009_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ophtha.2015.09.032","volume":"123","author":"MA Sadiq","year":"2016","unstructured":"Sadiq MA, Soliman MK, Sarwar S et al (2016) Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study. Ophthalmology 123:324\u2013329. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.032","journal-title":"Ophthalmology"},{"key":"4009_CR13","unstructured":"NICE (2013) Ranibizumab for treating diabetic ranibizumab for treating diabetic macular oedema macular oedema. [Online] Available at: \n                    https:\/\/www.nice.org.uk\/guidance\/ta274\/resources\/ranibizumab-for-treating-diabetic-macular-oedema-rapid-review-of-technology-appraisal-guidance-237-82600612458181"},{"key":"4009_CR14","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"C Wilkinson","year":"2003","unstructured":"Wilkinson C, Ferris FL, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677\u20131682. \n                    https:\/\/doi.org\/10.1016\/S0161-6420(03)00475-5","journal-title":"Ophthalmology"},{"key":"4009_CR15","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2147\/OPTH.S37340","volume":"6","author":"M Soman","year":"2012","unstructured":"Soman M, Ganekal S, Nair U, Nair K (2012) Effect of panretinal photocoagulation on macular morphology and thickness in eyes with proliferative diabetic retinopathy without clinically significant macular edema. Clin Ophthalmol 6:2013\u20132017. \n                    https:\/\/doi.org\/10.2147\/OPTH.S37340","journal-title":"Clin Ophthalmol"},{"key":"4009_CR16","doi-asserted-by":"publisher","first-page":"e2675","DOI":"10.1371\/journal.pone.0002675","volume":"3","author":"EJ Kuiper","year":"2008","unstructured":"Kuiper EJ, Van Nieuwenhoven FA, de Smet MD et al (2008) The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS One 3:e2675. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0002675","journal-title":"PLoS One"},{"key":"4009_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ophtha.2006.08.045","volume":"114","author":"G Ripandelli","year":"2007","unstructured":"Ripandelli G, Copp\u00e9 AM, Parisi V et al (2007) Posterior vitreous detachment and retinal detachment after cataract surgery. Ophthalmology 114:692\u2013697. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.045","journal-title":"Ophthalmology"},{"key":"4009_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0161-6420(97)30190-0","volume":"104","author":"P Mitchell","year":"1997","unstructured":"Mitchell P, Smith W, Chey T et al (1997) Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology 104:1033\u20131040","journal-title":"Ophthalmology"},{"key":"4009_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0161-6420(02)01443-4","volume":"110","author":"S Fraser-Bell","year":"2003","unstructured":"Fraser-Bell S, Guzowski M, Rochtchina E et al (2003) Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology 110:34\u201340","journal-title":"Ophthalmology"},{"key":"4009_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ajo.2012.10.007","volume":"155","author":"D Ivastinovic","year":"2013","unstructured":"Ivastinovic D, P\u00f6schl EM, Schwab C et al (2013) Evolution of early changes at the vitreoretinal interface after cataract surgery determined by optical coherence tomography and ultrasonography. Am J Ophthalmol 155:404\u2013405. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2012.10.007","journal-title":"Am J Ophthalmol"},{"key":"4009_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/archophthalmol.2012.1107","volume":"130","author":"SB Bressler","year":"2012","unstructured":"Bressler SB, Qin H, Beck RW et al (2012) Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol 130:1153. \n                    https:\/\/doi.org\/10.1001\/archophthalmol.2012.1107","journal-title":"Arch Ophthalmol"},{"key":"4009_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10792-013-9884-6","volume":"34","author":"D Yoon","year":"2014","unstructured":"Yoon D, Rusu I, Barbazetto I (2014) Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities. Int Ophthalmol 34:817\u2013823. \n                    https:\/\/doi.org\/10.1007\/s10792-013-9884-6","journal-title":"Int Ophthalmol"},{"key":"4009_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/jop.2011.0070","volume":"28","author":"P-C Wu","year":"2012","unstructured":"Wu P-C, Lai C-H, Chen C-L, Kuo C-N (2012) Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment. J Ocul Pharmacol Ther 28:59\u201364. \n                    https:\/\/doi.org\/10.1089\/jop.2011.0070","journal-title":"J Ocul Pharmacol Ther"},{"key":"4009_CR24","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0161-6420(88)33004-6","volume":"95","author":"FP Nasrallah","year":"1988","unstructured":"Nasrallah FP, Jalkh AE, Van Coppenolle F et al (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95:1335\u20131339","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4009-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4009-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4009-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T10:10:03Z","timestamp":1562926203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4009-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,19]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4009"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4009-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,19]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This was part of an audit approved by the Belfast Health and Social Care Trust (4966); full ethical review was therefore waived. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}